Compile Data Set for Download or QSAR
Report error Found 72 Enz. Inhib. hit(s) with all data for entry = 7547
TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200756BDBM200756(US9233111, 1)
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200783BDBM200783(US9233111, 17)
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200860BDBM200860(US9233111, 47)
Affinity DataIC50: 2nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200888BDBM200888(US9233111, 63)
Affinity DataIC50: 2nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200887BDBM200887(US9233111, 62)
Affinity DataIC50: 2nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200778BDBM200778(US9233111, 16)
Affinity DataIC50: 2nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200768BDBM200768(US9233111, 6)
Affinity DataIC50: 2nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200802BDBM200802(US9233111, 25)
Affinity DataIC50: 2nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200881BDBM200881(US9233111, 56)
Affinity DataIC50: 2nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200766BDBM200766(US9233111, 4)
Affinity DataIC50: 2nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200817BDBM200817(US9233111, 31)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200884BDBM200884(US9233111, 59)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200769BDBM200769(US9233111, 7)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200770BDBM200770(US9233111, 8)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200767BDBM200767(US9233111, 5)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200819BDBM200819(US9233111, 33)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200775BDBM200775(US9233111, 13)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200774BDBM200774(US9233111, 12)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200878BDBM200878(US9233111, 55)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200764BDBM200764(US9233111, 2)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200825BDBM200825(US9233111, 36)
Affinity DataIC50: 4nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200773BDBM200773(US9233111, 11)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200771BDBM200771(US9233111, 9)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200765BDBM200765(US9233111, 3)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200816BDBM200816(US9233111, 30)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200886BDBM200886(US9233111, 61)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200784BDBM200784(US9233111, 18)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200789BDBM200789(US9233111, 21)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200786BDBM200786(US9233111, 20)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200818BDBM200818(US9233111, 32)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200866BDBM200866(US9233111, 48)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200882BDBM200882(US9233111, 57)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200854BDBM200854(US9233111, 45)
Affinity DataIC50: 8nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200885BDBM200885(US9233111, 60)
Affinity DataIC50: 8nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200790BDBM200790(US9233111, 22)
Affinity DataIC50: 8nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200901BDBM200901(US9233111, 67)
Affinity DataIC50: 8nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200897BDBM200897(US9233111, 65)
Affinity DataIC50: 9nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200794BDBM200794(US9233111, 23)
Affinity DataIC50: 12nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200898BDBM200898(US9233111, 66)
Affinity DataIC50: 12nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200811BDBM200811(US9233111, 29)
Affinity DataIC50: 13nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200838BDBM200838(US9233111, 39)
Affinity DataIC50: 13nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200824BDBM200824(US9233111, 35)
Affinity DataIC50: 14nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200891BDBM200891(US9233111, 64)
Affinity DataIC50: 15nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200772BDBM200772(US9233111, 10)
Affinity DataIC50: 15nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200776BDBM200776(US9233111, 14)
Affinity DataIC50: 16nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200883BDBM200883(US9233111, 58)
Affinity DataIC50: 16nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200777BDBM200777(US9233111, 15)
Affinity DataIC50: 17nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200857BDBM200857(US9233111, 46)
Affinity DataIC50: 17nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200851BDBM200851(US9233111, 44)
Affinity DataIC50: 17nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 200844BDBM200844(US9233111, 40)
Affinity DataIC50: 19nMpH: 7.5 T: 2°CAssay Description:The inhibitory activity of the present compounds against Btk was assessed in a biochemical enzyme assay. Assay plates in 384 well format were prepare...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2016
Entry Details
US Patent

Displayed 1 to 50 (of 72 total ) | Next | Last >>
Jump to: